Lee E. Melancon

Publications by Year

Research Areas

Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Genetic Associations and Epidemiology, Liver Disease Diagnosis and Treatment

Most-Cited Works

• → Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2021)95 cited
• → The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures(2020)69 cited
• → Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience(2022)29 cited
• → Association of Metformin With the Development of Age-Related Macular Degeneration(2022)24 cited
• → Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)(2022)15 cited
• → The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact(2025)13 cited
• → Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure(2024)10 cited
• → The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)(2022)4 cited
• → Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks(2025)2 cited
• → Successful strategies for recruiting African Americans to prevention trials(1998)2 cited